BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11790975)

  • 1. Proposed changes in the definitions of acute myeloid leukemia and myelodysplastic syndrome: are they helpful?
    Head DR
    Curr Opin Oncol; 2002 Jan; 14(1):19-23. PubMed ID: 11790975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [WHO classification of acute myeloid leukaemia (AML) and the myelodysplastic syndrome (MDS)].
    Haferlach T; Schoch C
    Dtsch Med Wochenschr; 2002 Mar; 127(9):447-50. PubMed ID: 11870559
    [No Abstract]   [Full Text] [Related]  

  • 3. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count.
    Chan GC; Wang WC; Raimondi SC; Behm FG; Krance RA; Chen G; Freiberg A; Ingram L; Butler D; Head DR
    Leukemia; 1997 Feb; 11(2):206-11. PubMed ID: 9009082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of myeloid neoplasms: a comparative review.
    McManus PM
    Vet Clin Pathol; 2005 Sep; 34(3):189-212. PubMed ID: 16134066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. World Health Organization classification of myelodysplastic syndromes.
    Czader M; Orazi A
    Curr Pharm Des; 2012; 18(22):3149-62. PubMed ID: 22571693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias.
    Amin HM; Yang Y; Shen Y; Estey EH; Giles FJ; Pierce SA; Kantarjian HM; O'Brien SM; Jilani I; Albitar M
    Leukemia; 2005 Sep; 19(9):1567-72. PubMed ID: 16049515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant.
    Singh ZN; Huo D; Anastasi J; Smith SM; Karrison T; Le Beau MM; Larson RA; Vardiman JW
    Am J Clin Pathol; 2007 Feb; 127(2):197-205. PubMed ID: 17210514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytomorphology of acute myeloid leukemia and myelodysplastic syndromes].
    Kuriyama K
    Rinsho Ketsueki; 2006 Aug; 47(8):701-9. PubMed ID: 16986708
    [No Abstract]   [Full Text] [Related]  

  • 10. Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals.
    Strupp C; Gattermann N; Giagounidis A; Aul C; Hildebrandt B; Haas R; Germing U
    Leuk Res; 2003 May; 27(5):397-404. PubMed ID: 12620291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes.
    Goasguen JE; Bennett JM; Bain BJ; Brunning R; Vallespi MT; Tomonaga M; Zini G; Renault A;
    Leuk Res; 2014 Apr; 38(4):447-53. PubMed ID: 24439566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B Study.
    Bernstein SH; Brunetto VL; Davey FR; Wurster-Hill D; Mayer RJ; Stone RM; Schiffer CA; Bloomfield CD
    J Clin Oncol; 1996 Sep; 14(9):2486-94. PubMed ID: 8823327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases.
    Hasle H; Niemeyer CM; Chessells JM; Baumann I; Bennett JM; Kerndrup G; Head DR
    Leukemia; 2003 Feb; 17(2):277-82. PubMed ID: 12592323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelodysplastic syndromes and acute myeloid leukemia. Diagnostic criteria and pitfalls.
    Farhi DC
    Pathol Annu; 1995; 30 ( Pt 1)():29-57. PubMed ID: 7731744
    [No Abstract]   [Full Text] [Related]  

  • 15. Myelodysplastic syndrome is not merely "preleukemia".
    Albitar M; Manshouri T; Shen Y; Liu D; Beran M; Kantarjian HM; Rogers A; Jilani I; Lin CW; Pierce S; Freireich EJ; Estey EH
    Blood; 2002 Aug; 100(3):791-8. PubMed ID: 12130488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
    Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S
    Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can t(8;21) oligoblastic leukemia be called a myelodysplastic syndrome?
    Kaneda K; Kojima K; Takeuchi M; Takimoto H; Takaba S; Shinagawa K; Kobayashi H; Miyata A; Hara M; Tanimoto M
    Eur J Haematol; 2002 Sep; 69(3):165-70. PubMed ID: 12406010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study Group.
    Greenberg P; Anderson J; de Witte T; Estey E; Fenaux P; Gupta P; Hamblin T; Hellstrom-Lindberg E; List A; Mufti G; Neuwirtova R; Ohyashiki K; Oscier D; Sanz G; Sanz M; Willman C
    J Clin Oncol; 2000 Oct; 18(19):3447-52. PubMed ID: 11013289
    [No Abstract]   [Full Text] [Related]  

  • 19. World Health Organization classification of the acute leukemias and myelodysplastic syndrome.
    Bennett JM
    Int J Hematol; 2000 Aug; 72(2):131-3. PubMed ID: 11039659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proposal for a type IV blast in the FAB classification.
    Wong KF; Chan JK
    Am J Hematol; 1995 Jun; 49(2):168. PubMed ID: 7771472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.